We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05321147
Brief Title: Safety and Efficacy of Lacutamab in Patients With Relapse Peripheral T-cell Lymphoma That Express KIR3DL2

First Submitted : April 4, 2022
First Submitted that Met QC Criteria : April 4, 2022
First Posted : April 11, 2022

Last Update Submitted that Met QC Criteria : April 4, 2022
Last Update Posted : April 11, 2022